US widens safety inquiry into AstraZeneca's coronavirus vaccine
FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustrationAstraZeneca’s vaccine study is being investigated further by the Food & Drug Administration after a participant experienced a suspected adverse reaction to the drug. This could put additional delays on the British drugmaker’s late-stage trial.
AstraZeneca’s CEO said on September 10 the vaccine would be ready by the end of the year or early next year, despite the COVID-19 trial halting due to the illness.The US Food and Drug Administration has broadened its investigation into the suspected adverse reaction of a participant in AstraZeneca's COVID-19 vaccine trial, whilst European regulators are set to announce its review as soon as this week.
on Wednesday. But these checks don't mean the agency suspects safety concerns with any of the vaccines, the people said.AstraZeneca's vaccine study, which is said to be one of the most advanced COVID-19 vaccines in the world, could be delayed even further due to the wider probe into safety issues carried out by the FDA.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Inside MatPat's Game Theory YouTube strategy and business: interview - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sourcesThe U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc&39;s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. AstraZeneca
Read more »
Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sourcesThe U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details...
Read more »
China Greenlights Another Covid-19 Vaccine for Human TestingA Chinese drugmaker, which is collaborating with AstraZeneca PLC on production of a coronavirus vaccine, has won approval from Chinese regulators to start testing one of its own vaccine candidates at home.
Read more »
Business Insider webinar on the race for a coronavirus vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Coronavirus death toll hits 1 million, but real number could be higher - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »